Global Immune Cell Therapy Drugs Market Research Report 2025(Status and Outlook)

March 2025 | 221 pages | ID: GF86D9937D9BEN
Bosson Research

Abstracts

Report Overview

Immune Cell Therapy is a medical treatment approach that involves modifying a patient's own immune cells, typically T cells, to enhance their ability to recognize and attack cancer cells or other diseases.

This report provides a deep insight into the global Immune Cell Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immune Cell Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immune Cell Therapy market in any manner.

Global Immune Cell Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Adaptimmune

Altor Bioscience Corporation

Cellectis

Juno Therapeutics

Kite Pharma

Novartis

Takara Bio

Unum Therapeutics

Market Segmentation (by Type)

T Cell Therapy

Natural Killer (NK) Cell Therapy

Other

Market Segmentation (by Application)

Stomach Cancer

Lung Cancer

Colorectal Cancer

Esophageal Cancer

Pancreatic Cancer

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Immune Cell Therapy Market
• Overview of the regional outlook of the Immune Cell Therapy Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immune Cell Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immune Cell Therapy Drugs
1.2 Key Market Segments
1.2.1 Immune Cell Therapy Drugs Segment by Type
1.2.2 Immune Cell Therapy Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Immune Cell Therapy Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Immune Cell Therapy Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Immune Cell Therapy Drugs Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Immune Cell Therapy Drugs Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Immune Cell Therapy Drugs Product Life Cycle
3.3 Global Immune Cell Therapy Drugs Sales by Manufacturers (2020-2025)
3.4 Global Immune Cell Therapy Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Immune Cell Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Immune Cell Therapy Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Immune Cell Therapy Drugs Manufacturing Sites, Area Served, Product Type
3.8 Immune Cell Therapy Drugs Market Competitive Situation and Trends
3.8.1 Immune Cell Therapy Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Immune Cell Therapy Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Immune Cell Therapy Drugs Industry Chain Analysis
4.1 Immune Cell Therapy Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immune Cell Therapy Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Immune Cell Therapy Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Immune Cell Therapy Drugs Market
5.7 ESG Ratings of Leading Companies
6 Global Immune Cell Therapy Drugs Market by Region
6.1 Global Immune Cell Therapy Drugs Market Size by Region
6.1.1 Global Immune Cell Therapy Drugs Market Size by Region
6.1.2 Global Immune Cell Therapy Drugs Market Size Market Share by Region
6.2 Global Immune Cell Therapy Drugs Sales by Region
6.2.1 Global Immune Cell Therapy Drugs Sales by Region
6.2.2 Global Immune Cell Therapy Drugs Sales Market Share by Region
7 North America Market Overview
7.1 North America Immune Cell Therapy Drugs Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Immune Cell Therapy Drugs Market Size by Type
7.3 North America Immune Cell Therapy Drugs Market Size by Application
8 Europe Market Overview
8.1 Europe Immune Cell Therapy Drugs Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Immune Cell Therapy Drugs Market Size by Type
8.3 Europe Immune Cell Therapy Drugs Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Immune Cell Therapy Drugs Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Immune Cell Therapy Drugs Market Size by Type
9.3 Asia-Pacific Immune Cell Therapy Drugs Market Size by Application
10 South America Market Overview
10.1 South America Immune Cell Therapy Drugs Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Immune Cell Therapy Drugs Market Size by Type
10.3 South America Immune Cell Therapy Drugs Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Immune Cell Therapy Drugs Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Immune Cell Therapy Drugs Market Size by Type
11.3 Middle East and Africa Immune Cell Therapy Drugs Market Size by Application
12 Immune Cell Therapy Drugs Market Production by Region
12.1 Global Production of Immune Cell Therapy Drugs by Region(2020-2025)
12.2 Global Immune Cell Therapy Drugs Revenue Market Share by Region (2020-2025)
12.3 Global Immune Cell Therapy Drugs Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Immune Cell Therapy Drugs Production
12.4.1 North America Immune Cell Therapy Drugs Production Growth Rate (2020-2025)
12.4.2 North America Immune Cell Therapy Drugs Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Immune Cell Therapy Drugs Production
12.5.1 Europe Immune Cell Therapy Drugs Production Growth Rate (2020-2025)
12.5.2 Europe Immune Cell Therapy Drugs Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Immune Cell Therapy Drugs Production (2020-2025)
12.6.1 Japan Immune Cell Therapy Drugs Production Growth Rate (2020-2025)
12.6.2 Japan Immune Cell Therapy Drugs Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Immune Cell Therapy Drugs Production (2020-2025)
12.7.1 China Immune Cell Therapy Drugs Production Growth Rate (2020-2025)
12.7.2 China Immune Cell Therapy Drugs Production, Revenue, Price and Gross Margin (2020-2025)
13 Immune Cell Therapy Drugs Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Immune Cell Therapy Drugs Sales Market Share by Type (2020-2033)
13.3 Global Immune Cell Therapy Drugs Market Size Market Share by Type (2020-2033)
13.4 Global Immune Cell Therapy Drugs Price by Type (2020-2033)
14 Immune Cell Therapy Drugs Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Immune Cell Therapy Drugs Market Sales by Application (2020-2033)
14.3 Global Immune Cell Therapy Drugs Market Size (M USD) by Application (2020-2033)
14.4 Global Immune Cell Therapy Drugs Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Aquila BioMedical
15.1.1 Aquila BioMedical Basic Information
15.1.2 Aquila BioMedical Immune Cell Therapy Drugs Product Overview
15.1.3 Aquila BioMedical Immune Cell Therapy Drugs Product Market Performance
15.1.4 Aquila BioMedical Business Overview
15.1.5 Aquila BioMedical SWOT Analysis
15.1.6 Aquila BioMedical Recent Developments
15.2 BPS Bioscience
15.2.1 BPS Bioscience Basic Information
15.2.2 BPS Bioscience Immune Cell Therapy Drugs Product Overview
15.2.3 BPS Bioscience Immune Cell Therapy Drugs Product Market Performance
15.2.4 BPS Bioscience Business Overview
15.2.5 BPS Bioscience SWOT Analysis
15.2.6 BPS Bioscience Recent Developments
15.3 Celentyx
15.3.1 Celentyx Basic Information
15.3.2 Celentyx Immune Cell Therapy Drugs Product Overview
15.3.3 Celentyx Immune Cell Therapy Drugs Product Market Performance
15.3.4 Celentyx Business Overview
15.3.5 Celentyx SWOT Analysis
15.3.6 Celentyx Recent Developments
15.4 Crown Bioscience
15.4.1 Crown Bioscience Basic Information
15.4.2 Crown Bioscience Immune Cell Therapy Drugs Product Overview
15.4.3 Crown Bioscience Immune Cell Therapy Drugs Product Market Performance
15.4.4 Crown Bioscience Business Overview
15.4.5 Crown Bioscience Recent Developments
15.5 DiscoverX Corporation
15.5.1 DiscoverX Corporation Basic Information
15.5.2 DiscoverX Corporation Immune Cell Therapy Drugs Product Overview
15.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Product Market Performance
15.5.4 DiscoverX Corporation Business Overview
15.5.5 DiscoverX Corporation Recent Developments
15.6 Explicyte
15.6.1 Explicyte Basic Information
15.6.2 Explicyte Immune Cell Therapy Drugs Product Overview
15.6.3 Explicyte Immune Cell Therapy Drugs Product Market Performance
15.6.4 Explicyte Business Overview
15.6.5 Explicyte Recent Developments
15.7 Genscript Biotech Corporation
15.7.1 Genscript Biotech Corporation Basic Information
15.7.2 Genscript Biotech Corporation Immune Cell Therapy Drugs Product Overview
15.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Product Market Performance
15.7.4 Genscript Biotech Corporation Business Overview
15.7.5 Genscript Biotech Corporation Recent Developments
15.8 HD Biosciences
15.8.1 HD Biosciences Basic Information
15.8.2 HD Biosciences Immune Cell Therapy Drugs Product Overview
15.8.3 HD Biosciences Immune Cell Therapy Drugs Product Market Performance
15.8.4 HD Biosciences Business Overview
15.8.5 HD Biosciences Recent Developments
15.9 Horizon Discovery Group
15.9.1 Horizon Discovery Group Basic Information
15.9.2 Horizon Discovery Group Immune Cell Therapy Drugs Product Overview
15.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Product Market Performance
15.9.4 Horizon Discovery Group Business Overview
15.9.5 Horizon Discovery Group Recent Developments
15.10 ImmunXperts
15.10.1 ImmunXperts Basic Information
15.10.2 ImmunXperts Immune Cell Therapy Drugs Product Overview
15.10.3 ImmunXperts Immune Cell Therapy Drugs Product Market Performance
15.10.4 ImmunXperts Business Overview
15.10.5 ImmunXperts Recent Developments
15.11 Molecular Imaging
15.11.1 Molecular Imaging Basic Information
15.11.2 Molecular Imaging Immune Cell Therapy Drugs Product Overview
15.11.3 Molecular Imaging Immune Cell Therapy Drugs Product Market Performance
15.11.4 Molecular Imaging Business Overview
15.11.5 Molecular Imaging Recent Developments
15.12 Promega Corporation,Personalis
15.12.1 Promega Corporation,Personalis Basic Information
15.12.2 Promega Corporation,Personalis Immune Cell Therapy Drugs Product Overview
15.12.3 Promega Corporation,Personalis Immune Cell Therapy Drugs Product Market Performance
15.12.4 Promega Corporation,Personalis Business Overview
15.12.5 Promega Corporation,Personalis Recent Developments
15.13 STC Biologics
15.13.1 STC Biologics Basic Information
15.13.2 STC Biologics Immune Cell Therapy Drugs Product Overview
15.13.3 STC Biologics Immune Cell Therapy Drugs Product Market Performance
15.13.4 STC Biologics Business Overview
15.13.5 STC Biologics Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Immune Cell Therapy Drugs Market Size by Type (M USD)
Table 4. Global Immune Cell Therapy Drugs Market Size by Application (M USD)
Table 5. Immune Cell Therapy Drugs Market Size Comparison by Region (M USD)
Table 6. Global Immune Cell Therapy Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Immune Cell Therapy Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Immune Cell Therapy Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Immune Cell Therapy Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy Drugs as of 2024)
Table 11. Global Market Immune Cell Therapy Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Immune Cell Therapy Drugs Manufacturing Sites and Area Served
Table 13. Manufacturers Immune Cell Therapy Drugs Product Type
Table 14. Global Immune Cell Therapy Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immune Cell Therapy Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Immune Cell Therapy Drugs Market Size Comparison by Region (M USD)
Table 26. Global Immune Cell Therapy Drugs Market Size by Region (2020-2033) & (M USD)
Table 27. Global Immune Cell Therapy Drugs Market Size Market Share by Region (2020-2033)
Table 28. Global Immune Cell Therapy Drugs Sales by Region (2020-2033) & (K MT)
Table 29. Global Immune Cell Therapy Drugs Sales Market Share by Region (2020-2033)
Table 30. North America Immune Cell Therapy Drugs Market Size by Country (2020-2033) & (M USD)
Table 31. North America Immune Cell Therapy Drugs Sales by Country (2020-2033) & (K MT)
Table 32. North America Immune Cell Therapy Drugs Sales by Type (K MT)
Table 33. North America Immune Cell Therapy Drugs Market Size by Type (M USD)
Table 34. North America Immune Cell Therapy Drugs Sales (K MT) by Type (2020-2033)
Table 35. North America Immune Cell Therapy Drugs Market Size (M USD) by Type (2020-2033)
Table 36. North America Immune Cell Therapy Drugs Sales by Application (K MT)
Table 37. North America Immune Cell Therapy Drugs Market Size by Application (M USD)
Table 38. North America Immune Cell Therapy Drugs Sales (K MT) by Application (2020-2033)
Table 39. North America Immune Cell Therapy Drugs Market Size (M USD) by Application (2020-2033)
Table 40. Europe Immune Cell Therapy Drugs Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Immune Cell Therapy Drugs Sales by Country (2020-2033) & (K MT)
Table 42. Europe Immune Cell Therapy Drugs Sales by Type (K MT)
Table 43. Europe Immune Cell Therapy Drugs Market Size by Type (M USD)
Table 44. Europe Immune Cell Therapy Drugs Sales (K MT) by Type (2020-2033)
Table 45. Europe Immune Cell Therapy Drugs Market Size (M USD) by Type (2020-2033)
Table 46. Europe Immune Cell Therapy Drugs Sales by Application (K MT)
Table 47. Europe Immune Cell Therapy Drugs Market Size by Application (M USD)
Table 48. Europe Immune Cell Therapy Drugs Sales (K MT) by Application (2020-2033)
Table 49. Europe Immune Cell Therapy Drugs Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Immune Cell Therapy Drugs Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Immune Cell Therapy Drugs Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Immune Cell Therapy Drugs Sales by Type (K MT)
Table 53. Asia-Pacific Immune Cell Therapy Drugs Market Size by Type (M USD)
Table 54. Asia-Pacific Immune Cell Therapy Drugs Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Immune Cell Therapy Drugs Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Immune Cell Therapy Drugs Sales by Application (K MT)
Table 57. Asia-Pacific Immune Cell Therapy Drugs Market Size by Application (M USD)
Table 58. Asia-Pacific Immune Cell Therapy Drugs Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Immune Cell Therapy Drugs Market Size (M USD) by Application (2020-2025)
Table 60. South America Immune Cell Therapy Drugs Market Size by Country (2020-2033) & (M USD)
Table 61. South America Immune Cell Therapy Drugs Sales by Country (2020-2033) & (K MT)
Table 62. South America Immune Cell Therapy Drugs Sales by Type (K MT)
Table 63. South America Immune Cell Therapy Drugs Market Size by Type (M USD)
Table 64. South America Immune Cell Therapy Drugs Sales (K MT) by Type (2020-2033)
Table 65. South America Immune Cell Therapy Drugs Market Size (M USD) by Type (2020-2033)
Table 66. South America Immune Cell Therapy Drugs Sales by Application (K MT)
Table 67. South America Immune Cell Therapy Drugs Market Size by Application (M USD)
Table 68. South America Immune Cell Therapy Drugs Sales (K MT) by Application (2020-2033)
Table 69. South America Immune Cell Therapy Drugs Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Immune Cell Therapy Drugs Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Immune Cell Therapy Drugs Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Immune Cell Therapy Drugs Sales by Type (K MT)
Table 73. Middle East and Africa Immune Cell Therapy Drugs Market Size by Type (M USD)
Table 74. Middle East and Africa Immune Cell Therapy Drugs Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Immune Cell Therapy Drugs Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Immune Cell Therapy Drugs Sales by Application (K MT)
Table 77. Middle East and Africa Immune Cell Therapy Drugs Market Size by Application (M USD)
Table 78. Middle East and Africa Immune Cell Therapy Drugs Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Immune Cell Therapy Drugs Market Size (M USD) by Application (2020-2033)
Table 80. Global Immune Cell Therapy Drugs Production (K MT) by Region(2020-2025)
Table 81. Global Immune Cell Therapy Drugs Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Immune Cell Therapy Drugs Revenue Market Share by Region (2020-2025)
Table 83. Global Immune Cell Therapy Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Immune Cell Therapy Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Immune Cell Therapy Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Immune Cell Therapy Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Immune Cell Therapy Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Immune Cell Therapy Drugs Sales by Type (K MT)
Table 89. Global Immune Cell Therapy Drugs Market Size by Type (M USD)
Table 90. Global Immune Cell Therapy Drugs Sales (K MT) by Type (2020-2033)
Table 91. Global Immune Cell Therapy Drugs Sales Market Share by Type (2020-2033)
Table 92. Global Immune Cell Therapy Drugs Market Size (M USD) by Type (2020-2033)
Table 93. Global Immune Cell Therapy Drugs Market Size Share by Type (2020-2033)
Table 94. Global Immune Cell Therapy Drugs Sales (K MT) by Application
Table 95. Global Immune Cell Therapy Drugs Market Size by Application(M USD)
Table 96. Global Immune Cell Therapy Drugs Sales by Application (2020-2033) & (K MT)
Table 97. Global Immune Cell Therapy Drugs Sales Market Share by Application (2020-2033)
Table 98. Global Immune Cell Therapy Drugs Market Size by Application (2020-2033) & (M USD)
Table 99. Global Immune Cell Therapy Drugs Market Share by Application (2020-2033)
Table 100. Global Immune Cell Therapy Drugs Sales Growth Rate by Application (2020-2033)
Table 101. Aquila BioMedical Basic Information
Table 102. Aquila BioMedical Immune Cell Therapy Drugs Product Overview
Table 103. Aquila BioMedical Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Aquila BioMedical Business Overview
Table 105. Aquila BioMedical SWOT Analysis
Table 106. Aquila BioMedical Recent Developments
Table 107. BPS Bioscience Basic Information
Table 108. BPS Bioscience Immune Cell Therapy Drugs Product Overview
Table 109. BPS Bioscience Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. BPS Bioscience Business Overview
Table 111. BPS Bioscience SWOT Analysis
Table 112. BPS Bioscience Recent Developments
Table 113. Celentyx Basic Information
Table 114. Celentyx Immune Cell Therapy Drugs Product Overview
Table 115. Celentyx Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Celentyx Business Overview
Table 117. Celentyx SWOT Analysis
Table 118. Celentyx Recent Developments
Table 119. Crown Bioscience Basic Information
Table 120. Crown Bioscience Immune Cell Therapy Drugs Product Overview
Table 121. Crown Bioscience Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Crown Bioscience Business Overview
Table 123. Crown Bioscience Recent Developments
Table 124. DiscoverX Corporation Basic Information
Table 125. DiscoverX Corporation Immune Cell Therapy Drugs Product Overview
Table 126. DiscoverX Corporation Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. DiscoverX Corporation Business Overview
Table 128. DiscoverX Corporation Recent Developments
Table 129. Explicyte Basic Information
Table 130. Explicyte Immune Cell Therapy Drugs Product Overview
Table 131. Explicyte Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Explicyte Business Overview
Table 133. Explicyte Recent Developments
Table 134. Genscript Biotech Corporation Basic Information
Table 135. Genscript Biotech Corporation Immune Cell Therapy Drugs Product Overview
Table 136. Genscript Biotech Corporation Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Genscript Biotech Corporation Business Overview
Table 138. Genscript Biotech Corporation Recent Developments
Table 139. HD Biosciences Basic Information
Table 140. HD Biosciences Immune Cell Therapy Drugs Product Overview
Table 141. HD Biosciences Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. HD Biosciences Business Overview
Table 143. HD Biosciences Recent Developments
Table 144. Horizon Discovery Group Basic Information
Table 145. Horizon Discovery Group Immune Cell Therapy Drugs Product Overview
Table 146. Horizon Discovery Group Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Horizon Discovery Group Business Overview
Table 148. Horizon Discovery Group Recent Developments
Table 149. ImmunXperts Basic Information
Table 150. ImmunXperts Immune Cell Therapy Drugs Product Overview
Table 151. ImmunXperts Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. ImmunXperts Business Overview
Table 153. ImmunXperts Recent Developments
Table 154. Molecular Imaging Basic Information
Table 155. Molecular Imaging Immune Cell Therapy Drugs Product Overview
Table 156. Molecular Imaging Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Molecular Imaging Business Overview
Table 158. Molecular Imaging Recent Developments
Table 159. Promega Corporation,Personalis Basic Information
Table 160. Promega Corporation,Personalis Immune Cell Therapy Drugs Product Overview
Table 161. Promega Corporation,Personalis Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Promega Corporation,Personalis Business Overview
Table 163. Promega Corporation,Personalis Recent Developments
Table 164. STC Biologics Basic Information
Table 165. STC Biologics Immune Cell Therapy Drugs Product Overview
Table 166. STC Biologics Immune Cell Therapy Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. STC Biologics Business Overview
Table 168. STC Biologics Recent Developments
List of Figures
Figure 1. Product Picture of Immune Cell Therapy Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immune Cell Therapy Drugs Market Size (M USD), 2024-2033
Figure 5. Global Immune Cell Therapy Drugs Market Size (M USD) (2020-2033)
Figure 6. Global Immune Cell Therapy Drugs Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immune Cell Therapy Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Immune Cell Therapy Drugs Product Life Cycle
Figure 13. Immune Cell Therapy Drugs Sales Share by Manufacturers in 2024
Figure 14. Global Immune Cell Therapy Drugs Revenue Share by Manufacturers in 2024
Figure 15. Immune Cell Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Immune Cell Therapy Drugs Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Immune Cell Therapy Drugs Revenue in 2024
Figure 18. Industry Chain Map of Immune Cell Therapy Drugs
Figure 19. Global Immune Cell Therapy Drugs Market PEST Analysis
Figure 20. Global Immune Cell Therapy Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Immune Cell Therapy Drugs Market Size by Region
Figure 27. Global Immune Cell Therapy Drugs Market Size Market Share by Region (2020-2033)
Figure 28. Global Immune Cell Therapy Drugs Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Immune Cell Therapy Drugs Market Size (M USD) by Country
Figure 33. USA Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Immune Cell Therapy Drugs Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Immune Cell Therapy Drugs Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Immune Cell Therapy Drugs Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Immune Cell Therapy Drugs Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Immune Cell Therapy Drugs Market Size (M USD)by Type
Figure 40. North America Immune Cell Therapy Drugs Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Immune Cell Therapy Drugs Market Size (M USD) by Country
Figure 45. Germany Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Immune Cell Therapy Drugs Market Size (M USD) by Type
Figure 56. Europe Immune Cell Therapy Drugs Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Immune Cell Therapy Drugs Market Size (M USD) by Country
Figure 61. China Immune Cell Therapy Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Immune Cell Therapy Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Immune Cell Therapy Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Immune Cell Therapy Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Immune Cell Therapy Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Immune Cell Therapy Drugs Market Size (M USD) by Type
Figure 72. Asia-Pacific Immune Cell Therapy Drugs Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Immune Cell Therapy Drugs Market Size (M USD) by Country
Figure 77. Brazil Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Immune Cell Therapy Drugs Market Size (M USD) by Type
Figure 84. South America Immune Cell Therapy Drugs Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Immune Cell Therapy Drugs Market Size (M USD) by Country
Figure 89. Saudi Arabia Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Immune Cell Therapy Drugs Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Immune Cell Therapy Drugs Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Immune Cell Therapy Drugs Market Size (M USD) by Type
Figure 100. Middle East and Africa Immune Cell Therapy Drugs Market Size (M USD) by Application
Figure 101. Global Immune Cell Therapy Drugs Production Market Share by Region (2020-2025)
Figure 102. North America Immune Cell Therapy Drugs Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Immune Cell Therapy Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Immune Cell Therapy Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. China Immune Cell Therapy Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Immune Cell Therapy Drugs Market Size by Type (M USD)
Figure 108. Sales Market Share of Immune Cell Therapy Drugs by Type (2020-2033)
Figure 109. Sales Market Share of Immune Cell Therapy Drugs by Type in 2024
Figure 110. Market Size Share of Immune Cell Therapy Drugs by Type (2020-2033)
Figure 111. Market Size Share of Immune Cell Therapy Drugs by Type in 2024
Figure 112. Global Immune Cell Therapy Drugs Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Immune Cell Therapy Drugs Market Size by Application(M USD)
Figure 115. Global Immune Cell Therapy Drugs Market Share by Application
Figure 116. Global Immune Cell Therapy Drugs Sales Market Share by Application (2020-2033)
Figure 117. Global Immune Cell Therapy Drugs Sales Market Share by Application in 2024
Figure 118. Global Immune Cell Therapy Drugs Market Share by Application (2020-2033)
Figure 119. Global Immune Cell Therapy Drugs Market Share by Application in 2024
Figure 120. Global Immune Cell Therapy Drugs Sales Growth Rate by Application (2020-2033)